CN115068668A - 一种核壳结构多孔水凝胶栓塞微球及其制备方式 - Google Patents
一种核壳结构多孔水凝胶栓塞微球及其制备方式 Download PDFInfo
- Publication number
- CN115068668A CN115068668A CN202210638298.3A CN202210638298A CN115068668A CN 115068668 A CN115068668 A CN 115068668A CN 202210638298 A CN202210638298 A CN 202210638298A CN 115068668 A CN115068668 A CN 115068668A
- Authority
- CN
- China
- Prior art keywords
- core
- porous
- microsphere
- layer
- microspheres
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004005 microsphere Substances 0.000 title claims abstract description 129
- 239000000017 hydrogel Substances 0.000 title claims abstract description 47
- 239000011258 core-shell material Substances 0.000 title claims abstract description 30
- 230000010102 embolization Effects 0.000 title claims description 36
- 238000002360 preparation method Methods 0.000 title claims description 15
- 239000003814 drug Substances 0.000 claims abstract description 71
- 229940079593 drug Drugs 0.000 claims abstract description 65
- 239000010410 layer Substances 0.000 claims abstract description 50
- 108010010803 Gelatin Proteins 0.000 claims abstract description 46
- 239000008273 gelatin Substances 0.000 claims abstract description 46
- 229920000159 gelatin Polymers 0.000 claims abstract description 46
- 235000019322 gelatine Nutrition 0.000 claims abstract description 46
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 46
- 239000004372 Polyvinyl alcohol Substances 0.000 claims abstract description 38
- 239000000499 gel Substances 0.000 claims abstract description 38
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract description 38
- 238000011068 loading method Methods 0.000 claims abstract description 24
- 239000012792 core layer Substances 0.000 claims abstract description 22
- 208000005189 Embolism Diseases 0.000 claims abstract description 13
- 239000002245 particle Substances 0.000 claims abstract description 8
- 230000009471 action Effects 0.000 claims abstract description 4
- 239000000126 substance Substances 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims description 40
- 239000007864 aqueous solution Substances 0.000 claims description 32
- 229920001223 polyethylene glycol Polymers 0.000 claims description 31
- 239000000839 emulsion Substances 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 238000001914 filtration Methods 0.000 claims description 27
- 239000011148 porous material Substances 0.000 claims description 26
- 239000000243 solution Substances 0.000 claims description 24
- 125000002091 cationic group Chemical group 0.000 claims description 19
- 229940057995 liquid paraffin Drugs 0.000 claims description 19
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 19
- 239000002202 Polyethylene glycol Substances 0.000 claims description 17
- 239000005457 ice water Substances 0.000 claims description 15
- 238000006116 polymerization reaction Methods 0.000 claims description 14
- 239000003995 emulsifying agent Substances 0.000 claims description 13
- 238000002791 soaking Methods 0.000 claims description 13
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims description 12
- 125000003172 aldehyde group Chemical group 0.000 claims description 10
- 239000008367 deionised water Substances 0.000 claims description 10
- 229910021641 deionized water Inorganic materials 0.000 claims description 10
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical class CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 claims description 10
- 238000005406 washing Methods 0.000 claims description 10
- IUXKEHURPNDODV-UHFFFAOYSA-N 3-(dimethylamino)-1-(2-methylprop-2-enoyloxy)pentane-3-sulfonic acid Chemical compound CN(C)C(CC)(S(=O)(=O)O)CCOC(C(=C)C)=O IUXKEHURPNDODV-UHFFFAOYSA-N 0.000 claims description 9
- 239000004115 Sodium Silicate Substances 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 9
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims description 9
- 229910052911 sodium silicate Inorganic materials 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- 239000000178 monomer Substances 0.000 claims description 7
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims description 6
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 claims description 5
- 238000005119 centrifugation Methods 0.000 claims description 5
- -1 kappa Chemical compound 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- AUXMPXIYBWFHDC-UHFFFAOYSA-N n-(2,2-dimethoxyethyl)-2,2-dimethylpropanamide Chemical compound COC(OC)CNC(=O)C(C)(C)C AUXMPXIYBWFHDC-UHFFFAOYSA-N 0.000 claims description 5
- 238000000967 suction filtration Methods 0.000 claims description 5
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims description 4
- 229960002949 fluorouracil Drugs 0.000 claims description 4
- 239000002262 Schiff base Substances 0.000 claims description 3
- 150000004753 Schiff bases Chemical class 0.000 claims description 3
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 3
- 230000003993 interaction Effects 0.000 claims description 3
- HAWSQZCWOQZXHI-FQEVSTJZSA-N 10-Hydroxycamptothecin Chemical compound C1=C(O)C=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 HAWSQZCWOQZXHI-FQEVSTJZSA-N 0.000 claims description 2
- AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 claims description 2
- HAWSQZCWOQZXHI-UHFFFAOYSA-N CPT-OH Natural products C1=C(O)C=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 HAWSQZCWOQZXHI-UHFFFAOYSA-N 0.000 claims description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 claims description 2
- HTIJFSOGRVMCQR-UHFFFAOYSA-N Epirubicin Natural products COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(=O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO HTIJFSOGRVMCQR-UHFFFAOYSA-N 0.000 claims description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 2
- 238000006136 alcoholysis reaction Methods 0.000 claims description 2
- 229960004397 cyclophosphamide Drugs 0.000 claims description 2
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 claims description 2
- 229960004679 doxorubicin Drugs 0.000 claims description 2
- 229960001904 epirubicin Drugs 0.000 claims description 2
- 229960002897 heparin Drugs 0.000 claims description 2
- 229920000669 heparin Polymers 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- LPDGSXKSFUQEFD-UHFFFAOYSA-N n-(2-methoxy-2-methylpropyl)-2,2-dimethylpropanamide Chemical compound COC(C)(C)CNC(=O)C(C)(C)C LPDGSXKSFUQEFD-UHFFFAOYSA-N 0.000 claims description 2
- 238000012688 inverse emulsion polymerization Methods 0.000 abstract 2
- 206010014513 Embolism arterial Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 10
- 210000004204 blood vessel Anatomy 0.000 description 9
- 230000036770 blood supply Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 230000006835 compression Effects 0.000 description 5
- 238000007906 compression Methods 0.000 description 5
- 239000002246 antineoplastic agent Substances 0.000 description 4
- 229940044683 chemotherapy drug Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000010108 arterial embolization Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 230000003073 embolic effect Effects 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 206010016807 Fluid retention Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- HPLFXTUAVXJDPJ-UHFFFAOYSA-M (3-chloro-2-hydroxypropyl)-triethylazanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC(O)CCl HPLFXTUAVXJDPJ-UHFFFAOYSA-M 0.000 description 1
- CSPHGSFZFWKVDL-UHFFFAOYSA-M (3-chloro-2-hydroxypropyl)-trimethylazanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC(O)CCl CSPHGSFZFWKVDL-UHFFFAOYSA-M 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000005489 elastic deformation Effects 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 238000000879 optical micrograph Methods 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 150000003384 small molecules Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000011521 systemic chemotherapy Methods 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/104—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0031—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0036—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/046—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/622—Microcapsules
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210638298.3A CN115068668B (zh) | 2022-06-08 | 2022-06-08 | 一种核壳结构多孔水凝胶栓塞微球及其制备方式 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210638298.3A CN115068668B (zh) | 2022-06-08 | 2022-06-08 | 一种核壳结构多孔水凝胶栓塞微球及其制备方式 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115068668A true CN115068668A (zh) | 2022-09-20 |
CN115068668B CN115068668B (zh) | 2023-05-09 |
Family
ID=83251224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210638298.3A Active CN115068668B (zh) | 2022-06-08 | 2022-06-08 | 一种核壳结构多孔水凝胶栓塞微球及其制备方式 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115068668B (zh) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040225077A1 (en) * | 2002-12-30 | 2004-11-11 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
CN1878514A (zh) * | 2003-11-20 | 2006-12-13 | 血管技术国际股份公司 | 软组织植入物和抗瘢痕形成剂 |
CN105534952A (zh) * | 2016-01-08 | 2016-05-04 | 福建师范大学 | 一种核壳结构复合多孔微球的制备方法 |
CN108014376A (zh) * | 2017-11-20 | 2018-05-11 | 华南理工大学 | 一种甜菜碱修饰壳聚糖的多糖水凝胶及其制备方法 |
CN111849218A (zh) * | 2019-04-26 | 2020-10-30 | 深圳先进技术研究院 | 材料的表面改性方法及其改性后的材料和应用、医疗产品 |
CN111939310A (zh) * | 2020-08-28 | 2020-11-17 | 四川轻化工大学 | 一种聚乙烯醇-果胶栓塞微球、载药栓塞微球及制备方法 |
CN113272347A (zh) * | 2018-11-21 | 2021-08-17 | 株式会社可乐丽 | 单分散性水凝胶颗粒 |
CN113332499A (zh) * | 2021-03-17 | 2021-09-03 | 上海玮沐医疗科技有限公司 | 一种自控温光热效应微球及其制备方法 |
US20220168472A1 (en) * | 2019-03-13 | 2022-06-02 | Susmita Bose | Enzyme-degradable hydrogel for delivery of a payload |
-
2022
- 2022-06-08 CN CN202210638298.3A patent/CN115068668B/zh active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040225077A1 (en) * | 2002-12-30 | 2004-11-11 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
CN1878514A (zh) * | 2003-11-20 | 2006-12-13 | 血管技术国际股份公司 | 软组织植入物和抗瘢痕形成剂 |
CN105534952A (zh) * | 2016-01-08 | 2016-05-04 | 福建师范大学 | 一种核壳结构复合多孔微球的制备方法 |
CN108014376A (zh) * | 2017-11-20 | 2018-05-11 | 华南理工大学 | 一种甜菜碱修饰壳聚糖的多糖水凝胶及其制备方法 |
CN113272347A (zh) * | 2018-11-21 | 2021-08-17 | 株式会社可乐丽 | 单分散性水凝胶颗粒 |
US20220168472A1 (en) * | 2019-03-13 | 2022-06-02 | Susmita Bose | Enzyme-degradable hydrogel for delivery of a payload |
CN111849218A (zh) * | 2019-04-26 | 2020-10-30 | 深圳先进技术研究院 | 材料的表面改性方法及其改性后的材料和应用、医疗产品 |
CN111939310A (zh) * | 2020-08-28 | 2020-11-17 | 四川轻化工大学 | 一种聚乙烯醇-果胶栓塞微球、载药栓塞微球及制备方法 |
CN113332499A (zh) * | 2021-03-17 | 2021-09-03 | 上海玮沐医疗科技有限公司 | 一种自控温光热效应微球及其制备方法 |
Non-Patent Citations (5)
Title |
---|
JIELAI YANG: "Ball-bearing-inspired polyampholyte-modified microspheres as bio-lubricants attenuate osteoarthritis" * |
LI ZHANG: "An organic hydrogel with high-strength, high-water retention properties for pressure sore protection" * |
PEIXOTO LUCIANA S: "Expanded Core/Shell Poly(vinyl acetate)/poly(vinyl alcohol) Particles for embolization))" * |
田丰: "核壳结构聚合物微容器的制备及其医用前景" * |
许利娜: "甲基丙烯酰乙基磺基甜菜碱类聚合物的生物应用" * |
Also Published As
Publication number | Publication date |
---|---|
CN115068668B (zh) | 2023-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11786630B2 (en) | Polymer particles | |
US7056957B2 (en) | Formation of strong superporous hydrogels | |
CN107854720B (zh) | 具有造影功能的可载药多羟基聚合物栓塞微球及其制备方法 | |
Horak et al. | Hydrogels in endovascular embolization. III. Radiopaque spherical particles, their preparation and properties | |
US20020009415A1 (en) | Microspheres for use in the treatment of cancer | |
WO2015179997A1 (zh) | 多羟基聚合体栓塞微球及其制备工艺 | |
CN107899066B (zh) | 阳离子多羟基聚合物栓塞微球及其制备方法 | |
EP2073792A2 (en) | Superporous hydrogels | |
CN114470308A (zh) | 一种大孔聚丙烯酸钠栓塞微球的制备工艺 | |
CN113797383A (zh) | 一种高弹性、高载药量的栓塞微球及其制备方法 | |
CN114539464B (zh) | 一种栓塞微球及其制备方法和应用 | |
CN114917399A (zh) | 三种高分子微球及其制备方法和应用 | |
CN115068668A (zh) | 一种核壳结构多孔水凝胶栓塞微球及其制备方式 | |
CN112080032A (zh) | 基于机械应力敏感的自热式响应的微凝胶的制备方法 | |
JPWO2011040310A1 (ja) | 薬剤吸着材料およびそれを備えた医療用具 | |
CN115120749A (zh) | 一种放疗微球的制备方法及放疗微球 | |
CN115068669B (zh) | 一种三重网络多孔栓塞微球及其制备方法 | |
CN113372474B (zh) | 一种血液灌流树脂及其制备方法和应用 | |
CN116271186A (zh) | 一种可载药栓塞微球及其制备方法 | |
Fu et al. | Preparation of tryptophan modified chitosan beads and their adsorption of low density lipoprotein | |
JPH0626568B2 (ja) | 保存安定性の改良された体外循環治療用吸着カラム | |
US20230347012A1 (en) | Bioresorbable embolization particles | |
CN109046282B (zh) | 血液灌流和水溶液清除内毒素用的吸附剂及其制备方法 | |
JP2008195686A (ja) | 遺伝子導入活性を有する多孔体 | |
CN114533939A (zh) | 一种单分散聚丙烯酸钠栓塞微球的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20220920 Assignee: Zhuzhou ruidel Intelligent Equipment Co.,Ltd. Assignor: HUNAN University OF TECHNOLOGY Contract record no.: X2023980048585 Denomination of invention: A core-shell porous water gel embolic microsphere and its preparation method Granted publication date: 20230509 License type: Common License Record date: 20231129 Application publication date: 20220920 Assignee: ZHUZHOU HONGDA POLYMER MATERIALS Co.,Ltd. Assignor: HUNAN University OF TECHNOLOGY Contract record no.: X2023980048584 Denomination of invention: A core-shell porous water gel embolic microsphere and its preparation method Granted publication date: 20230509 License type: Common License Record date: 20231129 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20220920 Assignee: ZHUZHOU AMALLOY MATERIAL Co.,Ltd. Assignor: HUNAN University OF TECHNOLOGY Contract record no.: X2023980048989 Denomination of invention: A core-shell porous water gel embolic microsphere and its preparation method Granted publication date: 20230509 License type: Common License Record date: 20231204 |